EUVIMEDEUVIMED entdecken
Fallbericht

Lupus Peritonitis Development in a Patient with Coronavirus Disease 2019 on Peritoneal Dialysis: A Case Report

Kosuke Yamaka, Daiki Aomura, Makoto Harada, Takayuki Nimura, Koji Hashimoto, Yuji Kamijo

The Tohoku Journal of Experimental Medicine · 2025

DOI: 10.1620/tjem.2024.j110 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2025. Verfasst von Kosuke Yamaka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shinshu University School of Medicine. Hauptthemen laut MEDLINE: COVID-19, Peritonitis, Peritoneal Dialysis, Lupus Nephritis. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite receiving immunosuppressive therapy, a 37-year-old woman with lupus nephritis experienced refractory nephrotic syndrome and severe kidney dysfunction that necessitated peritoneal dialysis. Thereafter, immunosuppressants were tapered because her lupus symptoms improved. Two weeks after prednisolone termination, she was hospitalized because of acute abdominal pain. A physical examination revealed upper abdominal tenderness. Her dialysate was cloudy and comprised an elevated neutrophil count. A coronavirus disease 2019 test yielded positive results. Infectious peritonitis was suspected, coronavirus disease 2019 was diagnosed, and antibiotic and steroid therapies were initiated. The patient's symptoms improved rapidly, and steroid therapy was discontinued on day 9. On day 10, she experienced abdominal pain and exhibited an elevated monocyte-predominant dialysate cell count despite antibiotic treatment. The dialysate culture results were negative. Lupus peritonitis was suspected because of her slightly elevated dsDNA antibodies and changes in the dialysate cell fraction. Prednisolone was resumed on day 12. Her symptoms improved immediately, and she was discharged on day 30 without complications. This case highlights unique autoimmune activation by coronavirus disease 2019 (COVID-19) that resulted in unexpected pathological shifts and challenging diagnoses. Clinicians should consider various causes of immune flare-ups in patients with COVID-19 and autoimmune conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PeritonitisPeritoneal DialysisLupus NephritisHumansFemaleAdultSARS-CoV-2Prednisolone

Stichwörter der Autor:innen

coronavirus disease 2019end-stage kidney diseaselupus peritonitisperitoneal dialysissystemic lupus erythematosus

Substanzen

Prednisolone

Autor:innen und Institutionen

  • Department of Nephrology, Shinshu University School of Medicine.

Zitieren

APA

Yamaka, K., Aomura, D., Harada, M., Nimura, T., Hashimoto, K., & Kamijo, Y. (2025). Lupus Peritonitis Development in a Patient with Coronavirus Disease 2019 on Peritoneal Dialysis: A Case Report. The Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.2024.j110

Vancouver

Yamaka K, Aomura D, Harada M, Nimura T, Hashimoto K, Kamijo Y. Lupus Peritonitis Development in a Patient with Coronavirus Disease 2019 on Peritoneal Dialysis: A Case Report. The Tohoku Journal of Experimental Medicine. 2025. doi:10.1620/tjem.2024.j110

BibTeX
@article{Yamaka2025,
  author = {Yamaka, Kosuke and Aomura, Daiki and Harada, Makoto and Nimura, Takayuki and Hashimoto, Koji and Kamijo, Yuji},
  title = {Lupus Peritonitis Development in a Patient with Coronavirus Disease 2019 on Peritoneal Dialysis: A Case Report},
  journal = {The Tohoku Journal of Experimental Medicine},
  year = {2025},
  doi = {10.1620/tjem.2024.j110}
}
Kostenlos starten →